Page 25 - Laser Pointer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hello this is bbc news with martine croxall. the headlines... celebrations outside the court

Come in. but that seems unlikely, willie. >> so despite that possible continuation in the use of the j&j vaccine, the white house seems to have written off the pharmaceutical shots. privately, senior health officials have grown frustrated with the company's production issues and concluded it can be be counted on until it gets the go ahead to resume shots. the company has faced several setbacks including a contractor mix-up revealing safety and hygiene concerns as well as the rare blood clot disorder. according to two people with direct knowledge of the situation, if testing of the vaccine reve...

Happen an hour from now. >> the cdc is investigating another case of a woman that passed away after getting the vaccine. but we're told it is under way and no conclusions can be drawn until it is ccompleted. all indications was that they would recommend lifting that pause given that this period has been a wait and see period. they say we have waiting and we have not seen a crush of additional indications demonstrating this condition, this rare blood clotting condition combined with low platelets. this is important for vaccine confidence given the pause went on longer than what they terribly an...

Pettypiece, heidi przbyla is here in washington, and with us from miami is nbc news correspondent sam brock. the cdc advisory panel have been meeting throughout the day. i know you've been watching it. what are the takeaways and what are we expecting, when are we expecting an update from the fda on this issue? >> geoff, the headline so far, there's been no crush of additional data showing there's increased risk of these blood clots, these rare blood clots that we saw in a handful of individuals and that is why, geoff, the expectation remains that most likely this pause will be lifted with some...

Vaccine, the white house seems to have written off the shot. and they are frustrated with the production issues and have concluded it can't be counted on. and several setbacks including a contractor mix-up that ruined 15 million doses revealing serious safety and hygiene concerns as well as the rare blood clot disorder. according to two people with direct knowledge of the situation, if testing of the vaccine reveals more contamination, it could take j&j four months to replace doses at other facilities. joining us now washington correspondent for "the new york times," cheryl stolberg, good mo...